Recent Company News

• 05:26 AM ET Aug 08, 2025
  

  NMPA approves Shandong Boan Biotechnology's Boyouping for glycemic control in adults with type 2 diabetes (HK$18.40, 0.00)

• 05:48 AM ET Aug 01, 2025
  

  StreetAccount Sector Summary - China Healthcare July Recap

• 04:03 AM ET Jul 29, 2025
  

  NMPA approves trial of Shanghai Pharmaceuticals's B019 for difficult-to-treat lupus (HK$12.84, 0.00)

• 06:01 AM ET Jul 25, 2025
  

  Shanghai Pharmaceuticals Holding to acquire additional 10% stake in Shanghai Industrial Investment Group Finance for CNY143M (HK$12.70, 0.00)

• 11:44 PM ET Jul 09, 2025
  

  Shanghai Pharmaceuticals Holding jumped +3.7% following H1 preliminary result (HK$12.26, +0.42)

• 04:36 AM ET Jul 09, 2025
  

  Shanghai Pharmaceuticals Holding guides H1 net income attributable CNY4.45B vs year-ago CNY2.94B (HK$11.84, 0.00)

• 05:25 AM ET Jul 04, 2025
  

  Shanghai Pharmaceuticals Holding controlling shareholder completes purchase of 74.0M H shares as announced on 13-Sep-24 (HK$11.86, 0.00)

• 08:38 PM ET Jun 26, 2025
  

  Shanghai Pharmaceuticals Holding initiated buy at SWS Research (26-Jun, timing uncertain) (HK$11.78, 0.00)

• 05:10 AM ET Jun 24, 2025
  

  Chinese regulators guide reasonable lending by financial institutions to education sector

• 12:19 AM ET Jun 05, 2025
  

  StreetAccount Sector Summary - China Healthcare May Recap